| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.6M | -18.0% |
| Cost of Revenue | $3.7M | -23.4% |
| Gross Profit | $31.0M | -17.3% |
| R&D Expense | $9.2M | -6.6% |
| SG&A Expense | $15.6M | -29.8% |
| Operating Income | -$3.1M | +55.5% |
| Pre-tax Income | -$5.7M | +39.5% |
| Income Tax | $0 | — |
| Net Income | -$5.7M | +39.5% |
| EPS (Basic) | -$2.30 | +51.5% |
| EPS (Diluted) | -$2.30 | +51.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.5M | -5.0% |
| Accounts Receivable | $1.6M | -40.3% |
| Current Assets | $16.8M | -11.6% |
| Total Assets | $19.6M | -10.1% |
| Current Liabilities | $34.7M | +582.6% |
| Total Liabilities | $34.7M | +1.3% |
| Stockholders' Equity | -$15.1M | -21.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.3M | +115.4% |
| Investing Cash Flow | -$1.5M | -11.2% |
| Financing Cash Flow | -$634K | -342.0% |